• Wondering if Agilent Technologies at US$118.65 is offering solid value or just fair pricing right now? This article breaks down what the current market price might be implying.
• The stock is up 2.7% over the last week and 4.2% over the last month, even though the year to date return stands at a 14.0% decline and the 1 year return is 10.0%. Taken together, these figures provide a mixed picture of sentiment and recent momentum.
• Recent coverage has focused on how Agilent Technologies fits into longer term themes in life sciences and diagnostics as investors reassess where they want exposure. That broader context helps explain why the stock has seen periods of weakness alongside pockets of renewed interest.
• Agilent Technologies currently holds a value score of 4/6. The rest of this article will compare different valuation approaches on that basis and conclude with a way to think about value that goes beyond any single metric.

Approach 1: Agilent Technologies Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model takes projections of a company’s future cash flows and discounts them back to today’s dollars to estimate what the business might be worth right now.

For Agilent Technologies, the model uses a 2 Stage Free Cash Flow to Equity approach. The latest twelve month free cash flow is about $1.01b. Analyst and extrapolated estimates suggest free cash flow reaching about $2.28b in 2035, with intermediate years such as 2026 at $1.12b and 2027 at $1.59b. Simply Wall St extends analyst inputs beyond the usual five year window to build a full ten year cash flow path.

Discounting those projected cash flows back to today produces an estimated intrinsic value of $132.70 per share, compared with the recent share price of $118.65. On this model, Agilent Technologies screens as about 10.6% undervalued.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Agilent Technologies is undervalued by 10.6%. Track this in your watchlist or portfolio, or discover 51 more high quality undervalued stocks.

Approach 2: Agilent Technologies Price vs Earnings

For profitable companies, the P/E ratio is a useful way to relate what you pay for the stock to the earnings the business is currently generating. It helps you see how many dollars investors are willing to pay today for each dollar of earnings.

What counts as a "normal" or "fair" P/E depends on how the market views a company’s growth prospects and risk. Higher expected growth or lower perceived risk can support a higher multiple, while lower growth or higher risk usually calls for a lower one.

Agilent Technologies currently trades on a P/E of 26.0x, compared with the Life Sciences industry average of about 36.5x and a peer group average of 38.3x. Simply Wall St also calculates a proprietary Fair Ratio of 21.8x for Agilent Technologies. This Fair Ratio reflects factors such as earnings growth, industry, profit margins, market cap and company specific risks.

Because the Fair Ratio is tailored to the company, it can be more informative than a simple comparison with broad industry or peer averages. On this basis, Agilent Technologies' actual P/E of 26.0x is above the Fair Ratio of 21.8x, so on this metric the stock currently screens as overvalued.

Result: OVERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 18 top founder-led companies.

Upgrade Your Decision Making: Choose your Agilent Technologies Narrative

Earlier it was mentioned that there is an even better way to understand valuation. Narratives bring your view of Agilent Technologies together in one place by linking the story you believe about its business, the forecast you think is reasonable for revenue, earnings and margins, and the fair value that falls out of those numbers. All of this is available within an easy tool on Simply Wall St's Community page that updates when new information like news or earnings arrives. It helps you compare that evolving fair value with the current share price. For example, one investor might build a bullish Agilent Technologies Narrative that lines up with a fair value near US$185 based on stronger expectations, while another might build a more cautious one closer to US$140. You can then see clearly which story you agree with and what price range it implies.

Do you think there's more to the story for Agilent Technologies? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.